ScreenerHero

ZVSAZyVersa Therapeutics Inc. Common Stock

NAS · US · Healthcare · Biotechnology · zyversa.com
0.1160USD+17.17%Mkt Cap: 939127 $P/E: —

ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. It develops drug development platforms, including Cholest…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap939.13K $
Enterprise Value1.79M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-24.95M $
Revenue/Share—
Last Price0.1160 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees6
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.02
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-0.06
EPS (TTM)-3.67
EPS (Forward)-4.80
52W Range
0.095010% of range0.3000
52W High0.3000 USD
52W Low0.0950 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE201.44%
ROA-7172.26%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.11M $
CapEx (TTM)—
FCF Margin—
FCF Yield-231.88%
Net Debt897.34K $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio0.05
Quick Ratio0.02
Book Value/Sh-1.7450 USD
Cash/Share0.0370 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateApr 26, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.8.10M
Float7.68M
Insiders0.02%
Institutions5.15%
Short Interest
Short Ratio0.3d
Short % Float7.38%
Short % Out.7.37%
Shares Short359.25K
Short (prev mo.)300.95K
Technical
SMA 500.1326 (-12.5%)
SMA 2000.1736 (-33.2%)
Beta0.86
S&P 52W Chg18.16%
Avg Vol (30d)9.86K
Avg Vol (10d)3.35K
Technical Indicators
RSI (14)48.0
MACD-0.0108
MACD Signal-0.0125
MACD Hist.+0.0017
BB Upper0.1304 USD
BB Middle0.1108 USD
BB Lower0.0912 USD
BB Width35.33%
ATR (14)0.0111 USD
Vol Ratio (20d)0.12x